Index - P/E - EPS (ttm) -1.57 Insider Own 66.51% Shs Outstand 161.95M Perf Week -10.18%
Market Cap 242.92M Forward P/E - EPS next Y -1.01 Insider Trans 0.00% Shs Float 54.24M Perf Month -7.98%
Enterprise Value 45.29M PEG - EPS next Q -0.33 Inst Own 22.97% Short Float 9.65% Perf Quarter 73.69%
Income -252.09M P/S - EPS this Y 7.62% Inst Trans -17.39% Short Ratio 4.05 Perf Half Y 26.05%
Sales 0.00M P/B 1.33 EPS next Y 28.56% ROA -80.25% Short Interest 5.23M Perf YTD -85.85%
Book/sh 1.13 P/C 1.12 EPS next 5Y 14.93% ROE -89.37% 52W High 17.19 -91.27% Perf Year -87.32%
Cash/sh 1.34 P/FCF - EPS past 3/5Y 0.69% - ROIC -124.38% 52W Low 0.61 145.50% Perf 3Y -
Dividend Est. - EV/EBITDA - Sales past 3/5Y - - Gross Margin - Volatility 5.06% 5.76% Perf 5Y -
Dividend TTM - EV/Sales - EPS Y/Y TTM 9.84% Oper. Margin - ATR (14) 0.11 Perf 10Y -
Dividend Ex-Date - Quick Ratio 10.54 Sales Y/Y TTM - Profit Margin - RSI (14) 39.82 Recom 2.50
Dividend Gr. 3/5Y - - Current Ratio 10.54 EPS Q/Q 11.67% SMA20 -9.53% Beta 2.93 Target Price 7.00
Payout - Debt/Eq 0.11 Sales Q/Q - SMA50 -9.51% Rel Volume 0.37 Prev Close 1.52
Employees 110 LT Debt/Eq 0.11 Earnings Aug 06 AMC SMA200 -38.28% Avg Volume 1.29M Price 1.50
IPO Sep 15, 2023 Option/Short Yes / Yes EPS/Sales Surpr. 8.99% -Trades
Volume 476,277 Change -1.32%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-16-25 Downgrade JP Morgan
Neutral → Underweight
Apr-02-25 Downgrade BofA Securities
Buy → Underperform
$1
Mar-10-25 Downgrade William Blair
Outperform → Mkt Perform
Mar-07-25 Downgrade Stifel
Buy → Hold
$6 → $2
Mar-07-25 Downgrade Guggenheim
Buy → Neutral
Jan-02-25 Downgrade RBC Capital Mkts
Outperform → Sector Perform
$29 → $4
Nov-05-24 Downgrade JP Morgan
Overweight → Neutral
$18 → $15
Oct-01-24 Initiated H.C. Wainwright
Buy
$30
Jul-22-24 Initiated Needham
Buy
$23
Jul-08-24 Initiated Mizuho
Outperform
$20
Dec-12-23 Initiated Deutsche Bank
Hold
$13
Oct-10-23 Initiated William Blair
Outperform
$26
Oct-10-23 Initiated Stifel
Buy
$26
Oct-10-23 Initiated RBC Capital Mkts
Outperform
$24
Oct-10-23 Initiated JP Morgan
Overweight
$21
Oct-10-23 Initiated Guggenheim
Buy
$22
Oct-10-23 Initiated BofA Securities
Buy
$18
Show Previous Ratings
Sep-16-25 09:35AM
Sep-02-25 07:00AM
Aug-20-25 12:13AM
Aug-08-25 05:07AM
Aug-06-25 04:05PM
10:23AM
Loading…
Jul-29-25 10:23AM
Jul-23-25 07:00AM
Jul-20-25 12:35AM
Jul-09-25 07:00AM
May-13-25 03:10AM
May-12-25 04:01PM
Apr-28-25 07:00AM
Apr-22-25 02:49AM
Apr-21-25 04:10PM
Mar-18-25 05:45AM
12:26PM
Loading…
Mar-07-25 12:26PM
07:08AM
Mar-04-25 08:30AM
06:25AM
Mar-03-25 07:00AM
Feb-28-25 05:45AM
Feb-26-25 08:46PM
Feb-25-25 05:45AM
Feb-18-25 05:45AM
Feb-13-25 10:33AM
07:00AM
Feb-11-25 05:45AM
Jan-04-25 08:00AM
Jan-03-25 07:20AM
Jan-02-25 05:07PM
04:22PM
Loading…
04:22PM
(Investor's Business Daily)
01:28PM
01:07PM
(Pharmaceutical Technology)
12:00PM
10:47AM
09:59AM
09:54AM
08:30AM
07:00AM
Nov-19-24 08:53AM
Nov-12-24 07:00AM
Nov-06-24 07:00AM
Oct-29-24 07:00AM
Aug-14-24 07:00AM
Aug-06-24 01:54PM
07:00AM
Jul-01-24 01:00AM
Jun-20-24 07:00AM
May-14-24 08:52AM
07:00AM
May-07-24 01:54PM
10:20AM
07:00AM
May-06-24 07:00AM
Apr-16-24 11:28AM
Apr-15-24 04:20PM
(Investor's Business Daily) -17.48%
12:17PM
08:45AM
07:47AM
06:36AM
06:30AM
Mar-13-24 07:00AM
Mar-07-24 02:52PM
07:00AM
Jan-22-24 07:00AM
Jan-10-24 08:32AM
Jan-02-24 07:00AM
Dec-17-23 12:35PM
Dec-12-23 07:00AM
Nov-27-23 07:00AM
Nov-01-23 07:00AM
Oct-30-23 07:00AM
Oct-10-23 07:00AM
Sep-28-23 07:54PM
(InvestorPlace) +11.84%
+6.73%
Sep-27-23 06:50PM
Sep-18-23 12:35PM
Sep-14-23 08:49PM
Neumora Therapeutics, Inc. is a clinical-stage biotechnology company. It offers a precision medicine approach for brain diseases through the integration of data science and neuroscience. The firm focuses on advancing medicines for therapeutically relevant targets implicated in CNS diseases, targeting novel mechanisms of action with best-in-class pharmacology. The company was founded by Paul L. Berns, Carol Suh and Mike Poole in November 2019 and is headquartered in Watertown, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Henry Gosebruch Officer Mar 12 '25 Proposed Sale 1.43 15,000 21,450 Mar 12 04:49 PM BERNS PAUL L See Remarks Feb 18 '25 Sale 1.69 13,871 23,468 7,405,004 Feb 20 05:14 PM Milligan Michael Lee See Remarks Feb 18 '25 Sale 1.69 1,978 3,351 22,470 Feb 20 05:14 PM Aurora Daljit Singh Chief Strategy Officer Feb 18 '25 Sale 1.68 8,565 14,347 88,935 Feb 20 05:13 PM Lenz Robert A. Head of R&D Feb 18 '25 Sale 1.67 5,614 9,383 309,092 Feb 20 05:12 PM Pinto Joshua President Feb 18 '25 Sale 1.67 8,048 13,477 76,952 Feb 20 05:11 PM Suh Carol Y. Officer Feb 18 '25 Proposed Sale 1.68 9,540 16,020 Feb 18 05:51 PM Milligan Michael Lee Officer Feb 18 '25 Proposed Sale 1.69 1,978 3,351 Feb 18 05:49 PM Pinto Joshua Officer Feb 18 '25 Proposed Sale 1.67 8,048 13,478 Feb 18 05:45 PM Lenz Robert A. Officer Feb 18 '25 Proposed Sale 1.67 5,614 9,383 Feb 18 05:43 PM Gosebruch Henry O Officer Feb 18 '25 Proposed Sale 1.67 6,857 11,462 Feb 18 05:41 PM BERNS PAUL L Officer Feb 18 '25 Proposed Sale 1.69 13,871 23,468 Feb 18 05:40 PM Aurora Daljit Singh Officer Feb 18 '25 Proposed Sale 1.68 8,565 14,348 Feb 18 05:38 PM Fust Matthew K Director Oct 18 '24 Option Exercise 5.29 14,049 74,309 34,149 Oct 18 06:25 PM Fust Matthew K Director Oct 17 '24 Option Exercise 6.81 7,739 52,730 27,839 Oct 18 06:25 PM Fust Matthew K Director Oct 18 '24 Sale 17.03 14,049 239,319 20,100 Oct 18 06:25 PM Fust Matthew K Director Oct 17 '24 Sale 17.01 7,739 131,643 20,100 Oct 18 06:25 PM Fust Matthew K Director Oct 18 '24 Proposed Sale 17.03 14,049 239,319 Oct 18 04:01 PM Fust Matthew K Director Oct 17 '24 Proposed Sale 17.01 7,739 131,643 Oct 17 04:26 PM Lenz Robert A. Head of R&D Oct 10 '24 Sale 15.09 8,260 124,603 314,706 Oct 11 04:10 PM Lenz Robert A. Head of R&D Oct 09 '24 Sale 15.01 5,563 83,507 322,966 Oct 11 04:10 PM Lenz Robert A. Officer Oct 10 '24 Proposed Sale 15.09 8,260 124,603 Oct 10 04:30 PM Lenz Robert A. Officer Oct 09 '24 Proposed Sale 15.01 5,563 83,507 Oct 09 04:10 PM Lenz Robert A. Head of R&D Sep 18 '24 Sale 12.09 10,676 129,091 328,529 Sep 19 04:35 PM Lenz Robert A. Officer Sep 18 '24 Proposed Sale 12.09 10,676 129,091 Sep 18 04:27 PM
